Your browser doesn't support javascript.
loading
Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study).
Rebuzzi, Sara Elena; Signori, Alessio; Banna, Giuseppe Luigi; Maruzzo, Marco; De Giorgi, Ugo; Pedrazzoli, Paolo; Sbrana, Andrea; Zucali, Paolo Andrea; Masini, Cristina; Naglieri, Emanuele; Procopio, Giuseppe; Merler, Sara; Tomasello, Laura; Fratino, Lucia; Baldessari, Cinzia; Ricotta, Riccardo; Panni, Stefano; Mollica, Veronica; Sorarù, Maria; Santoni, Matteo; Cortellini, Alessio; Prati, Veronica; Soto Parra, Hector Josè; Stellato, Marco; Atzori, Francesco; Pignata, Sandro; Messina, Carlo; Messina, Marco; Morelli, Franco; Prati, Giuseppe; Nolè, Franco; Vignani, Francesca; Cavo, Alessia; Roviello, Giandomenico; Pierantoni, Francesco; Casadei, Chiara; Bersanelli, Melissa; Chiellino, Silvia; Paolieri, Federico; Perrino, Matteo; Brunelli, Matteo; Iacovelli, Roberto; Porta, Camillo; Buti, Sebastiano; Fornarini, Giuseppe.
Afiliación
  • Rebuzzi SE; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino of Genova, Largo Rosanna Benzi 10, Genova, 16132, Italy.
  • Signori A; Department of Health Sciences, Section of Biostatistics, University of Genova, Genova, Italy.
  • Banna GL; Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK Cannizzaro Hospital, Catania, Italy.
  • Maruzzo M; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • De Giorgi U; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Pedrazzoli P; Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.
  • Sbrana A; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
  • Zucali PA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy.
  • Masini C; Medical Oncology Unit, AUSL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
  • Naglieri E; Division of Medical Oncology, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
  • Procopio G; SS Oncologia Medica Genitourinaria, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
  • Merler S; Department of Oncology, Azienda Ospedaliera Universitaria Integrata di Verona, University of Verona,Verona, Italy.
  • Tomasello L; Academic Unit of Medical Oncology, IRCCS Ospedale Policlinico San Martino of Genova, Genova, Italy.
  • Fratino L; Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano CRO-IRCCS, Aviano, Italy.
  • Baldessari C; Medical Oncology Unit, Department of Oncology and Hemathology, University Hospital of Modena, Modena, Italy.
  • Ricotta R; Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Panni S; Medical Oncology Unit, ASST - Istituti Ospitalieri Cremona Hospital, Cremona, Italy.
  • Mollica V; Oncologia Medica, Azienda Ospedaliero-Universitaria of Bologna, Bologna, Italy.
  • Sorarù M; U.O. Oncologia, Ospedale di Camposampiero, Italy.
  • Santoni M; Oncology Unit, Macerata Hospital, Macerata, Italy.
  • Cortellini A; Department of Biotechnology and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Prati V; Medical Oncology Unit, ASL CN 2, Alba-Bra, Italy.
  • Soto Parra HJ; Department of Oncology, Medical Oncology, University Hospital Policlinico-San Marco, Catania, Italy.
  • Stellato M; Department of Medical Oncology, Università Campus Bio-Medico of Roma, Rome, Italy.
  • Atzori F; Medical Oncology Department, University Hospital, University of Cagliari, Cagliari, Italy.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy.
  • Messina C; Medical Oncology Department, Santa Chiara Hospital, Trento, Italy.
  • Messina M; UOC Oncologia Medica, Istituto Fondazione G. Giglio, Cefalù, Italy.
  • Morelli F; Medical Oncology Department, Casa Sollievo Della Sofferenza Hospital, IRCCS, San Giovanni Rotondo, Italy.
  • Prati G; Department of oncology and advanced technologies AUSL - IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Nolè F; Medical Oncology Division of Urogenital & Head & Neck Tumors, IEO, European Institute of Oncology IRCCS, Milano, Italy.
  • Vignani F; Division of Medical Oncology, Ordine Mauriziano Hospital, Torino, Italy.
  • Cavo A; Oncology Unit, Villa Scassi Hospital, Genova, Italy.
  • Roviello G; Department of Health Sciences, Section of Clinical Pharmacology and Oncology, University of Firenze, Firenze, Italy.
  • Pierantoni F; Medical Oncology 1 Unit, Department of Oncology, Istituto Oncologico Veneto IOV IRCCS, Padova, Italy.
  • Casadei C; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Bersanelli M; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Chiellino S; Medical Oncology Unit, IRCCS Policlinico San Matteo, Pavia, Italy.
  • Paolieri F; Medical Oncology Unit 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy.
  • Perrino M; Department of Oncology, IRCCS, Humanitas Clinical and Research Center, Rozzano, Milano, Italy.
  • Brunelli M; Department of Diagnostics and Public Health, Pathology Unit, University and Hospital Trust of Verona, Verona, Italy.
  • Iacovelli R; Medical Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Porta C; Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari 'A. Moro', Bari, Italy.
  • Buti S; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
  • Fornarini G; Medical Oncology Unit 1, IRCCS Ospedale Policlinico San Martino of Genova, Genova, Italy.
Ther Adv Med Oncol ; 13: 17588359211019642, 2021.
Article en En | MEDLINE | ID: mdl-34046089
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2021 Tipo del documento: Article País de afiliación: Italia